BioVersys AG (FRA:W33) Inventories, Finished Goods: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:W33 BioVersys AG FRA:W33
16 GF Score
Price €28.60
View Full Analysis

What is BioVersys AG Inventories, Finished Goods?

BioVersys AG FRA:W33 +1.42% 16 Inventories, Finished Goods is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:W33 with a GF Score™ of 16/100.

BioVersys AG Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Inventories, Finished Goods Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Inventories, Finished Goods
0.00 0.00

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods 0.00 0.00 0.00 0.00
FRA:W33
16GF Score
BioVersys AG FRA:W33
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €0.00 Mil mean?
BioVersys AG (FRA:W33) has a Inventories, Finished Goods of €0.00 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Inventories, Finished Goods too high?
BioVersys AG's current Inventories, Finished Goods is €0.00 Mil. Overall, BioVersys AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Inventories, Finished Goods compare to VRTX and REGN?
BioVersys AG's Inventories, Finished Goods of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on BioVersys AG and its competitors. BioVersys AG's current Inventories, Finished Goods is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (FRA:W33) has a current Inventories, Finished Goods of €0.00 Mil. The current Inventories, Finished Goods is €0.00 Mil. BioVersys AG's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For BioVersys AG (FRA:W33), the current Inventories, Finished Goods is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKBIOV:Switzerland
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
16GF Score

Get the complete analysis for FRA:W33

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.60
Price